A phosphorylation switch regulates the transcriptional activation of cell cycle regulator p21 by histone deacetylase inhibitors

Elisabeth Simboeck, Anna Sawicka, Gordin Zupkovitz, Silvia Senese, Stefan Winter, Franck Dequiedt, Egon Ogris, Luciano Di Croce, Susanna Chiocca, Christian Seiser

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Histone deacetylase inhibitors induce cell cycle arrest and apoptosis in tumor cells and are, therefore, promising anticancer drugs. The cyclin-dependent kinase inhibitor p21 is activated in histone deacetylase (HDAC) inhibitor-treated tumor cells, and its growth-inhibitory function contributes to the anti-tumorigenic effect of HDAC inhibitors. We show here that induction of p21 by trichostatin A involves MAP kinase signaling. Activation of the MAP kinase signaling pathway by growth factors or stress signals results in histone H3 serine 10 phosphorylation at the p21 promoter and is crucial for acetylation of the neighboring lysine 14 and recruitment of activated RNA polymerase II in response to trichostatin A treatment. In non-induced cells, the protein phosphatase PP2A is associated with the p21 gene and counteracts its activation. Induction of p21 is linked to simultaneous acetylation and phosphorylation of histone H3. The dual modification mark H3S10phK14ac at the activated p21 promoter is recognized by the phospho-binding protein 14-3-3ζ, which protects the phosphoacetylation mark from being processed by PP2A. Taken together we have revealed a cross-talk of reversible phosphorylation and acetylation signals that controls the activation of p21 by HDAC inhibitors and identify the phosphatase PP2A as chromatin-associated transcriptional repressor in mammalian cells.

Original languageEnglish
Pages (from-to)41062-41073
Number of pages12
JournalJournal of Biological Chemistry
Volume285
Issue number52
DOIs
Publication statusPublished - Dec 24 2010

Fingerprint

Cyclin-Dependent Kinase Inhibitor p21
Phosphorylation
Histone Deacetylase Inhibitors
Acetylation
Transcriptional Activation
trichostatin A
Chemical activation
Cells
Switches
Histones
Tumors
Phosphotransferases
14-3-3 Proteins
MAP Kinase Signaling System
RNA Polymerase II
Phosphoprotein Phosphatases
Cell Cycle Checkpoints
Phosphoric Monoester Hydrolases
Serine
Lysine

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

A phosphorylation switch regulates the transcriptional activation of cell cycle regulator p21 by histone deacetylase inhibitors. / Simboeck, Elisabeth; Sawicka, Anna; Zupkovitz, Gordin; Senese, Silvia; Winter, Stefan; Dequiedt, Franck; Ogris, Egon; Di Croce, Luciano; Chiocca, Susanna; Seiser, Christian.

In: Journal of Biological Chemistry, Vol. 285, No. 52, 24.12.2010, p. 41062-41073.

Research output: Contribution to journalArticle

Simboeck, E, Sawicka, A, Zupkovitz, G, Senese, S, Winter, S, Dequiedt, F, Ogris, E, Di Croce, L, Chiocca, S & Seiser, C 2010, 'A phosphorylation switch regulates the transcriptional activation of cell cycle regulator p21 by histone deacetylase inhibitors', Journal of Biological Chemistry, vol. 285, no. 52, pp. 41062-41073. https://doi.org/10.1074/jbc.M110.184481
Simboeck, Elisabeth ; Sawicka, Anna ; Zupkovitz, Gordin ; Senese, Silvia ; Winter, Stefan ; Dequiedt, Franck ; Ogris, Egon ; Di Croce, Luciano ; Chiocca, Susanna ; Seiser, Christian. / A phosphorylation switch regulates the transcriptional activation of cell cycle regulator p21 by histone deacetylase inhibitors. In: Journal of Biological Chemistry. 2010 ; Vol. 285, No. 52. pp. 41062-41073.
@article{e0c7b7f7e78a47cca3f3610977a0b926,
title = "A phosphorylation switch regulates the transcriptional activation of cell cycle regulator p21 by histone deacetylase inhibitors",
abstract = "Histone deacetylase inhibitors induce cell cycle arrest and apoptosis in tumor cells and are, therefore, promising anticancer drugs. The cyclin-dependent kinase inhibitor p21 is activated in histone deacetylase (HDAC) inhibitor-treated tumor cells, and its growth-inhibitory function contributes to the anti-tumorigenic effect of HDAC inhibitors. We show here that induction of p21 by trichostatin A involves MAP kinase signaling. Activation of the MAP kinase signaling pathway by growth factors or stress signals results in histone H3 serine 10 phosphorylation at the p21 promoter and is crucial for acetylation of the neighboring lysine 14 and recruitment of activated RNA polymerase II in response to trichostatin A treatment. In non-induced cells, the protein phosphatase PP2A is associated with the p21 gene and counteracts its activation. Induction of p21 is linked to simultaneous acetylation and phosphorylation of histone H3. The dual modification mark H3S10phK14ac at the activated p21 promoter is recognized by the phospho-binding protein 14-3-3ζ, which protects the phosphoacetylation mark from being processed by PP2A. Taken together we have revealed a cross-talk of reversible phosphorylation and acetylation signals that controls the activation of p21 by HDAC inhibitors and identify the phosphatase PP2A as chromatin-associated transcriptional repressor in mammalian cells.",
author = "Elisabeth Simboeck and Anna Sawicka and Gordin Zupkovitz and Silvia Senese and Stefan Winter and Franck Dequiedt and Egon Ogris and {Di Croce}, Luciano and Susanna Chiocca and Christian Seiser",
year = "2010",
month = "12",
day = "24",
doi = "10.1074/jbc.M110.184481",
language = "English",
volume = "285",
pages = "41062--41073",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "52",

}

TY - JOUR

T1 - A phosphorylation switch regulates the transcriptional activation of cell cycle regulator p21 by histone deacetylase inhibitors

AU - Simboeck, Elisabeth

AU - Sawicka, Anna

AU - Zupkovitz, Gordin

AU - Senese, Silvia

AU - Winter, Stefan

AU - Dequiedt, Franck

AU - Ogris, Egon

AU - Di Croce, Luciano

AU - Chiocca, Susanna

AU - Seiser, Christian

PY - 2010/12/24

Y1 - 2010/12/24

N2 - Histone deacetylase inhibitors induce cell cycle arrest and apoptosis in tumor cells and are, therefore, promising anticancer drugs. The cyclin-dependent kinase inhibitor p21 is activated in histone deacetylase (HDAC) inhibitor-treated tumor cells, and its growth-inhibitory function contributes to the anti-tumorigenic effect of HDAC inhibitors. We show here that induction of p21 by trichostatin A involves MAP kinase signaling. Activation of the MAP kinase signaling pathway by growth factors or stress signals results in histone H3 serine 10 phosphorylation at the p21 promoter and is crucial for acetylation of the neighboring lysine 14 and recruitment of activated RNA polymerase II in response to trichostatin A treatment. In non-induced cells, the protein phosphatase PP2A is associated with the p21 gene and counteracts its activation. Induction of p21 is linked to simultaneous acetylation and phosphorylation of histone H3. The dual modification mark H3S10phK14ac at the activated p21 promoter is recognized by the phospho-binding protein 14-3-3ζ, which protects the phosphoacetylation mark from being processed by PP2A. Taken together we have revealed a cross-talk of reversible phosphorylation and acetylation signals that controls the activation of p21 by HDAC inhibitors and identify the phosphatase PP2A as chromatin-associated transcriptional repressor in mammalian cells.

AB - Histone deacetylase inhibitors induce cell cycle arrest and apoptosis in tumor cells and are, therefore, promising anticancer drugs. The cyclin-dependent kinase inhibitor p21 is activated in histone deacetylase (HDAC) inhibitor-treated tumor cells, and its growth-inhibitory function contributes to the anti-tumorigenic effect of HDAC inhibitors. We show here that induction of p21 by trichostatin A involves MAP kinase signaling. Activation of the MAP kinase signaling pathway by growth factors or stress signals results in histone H3 serine 10 phosphorylation at the p21 promoter and is crucial for acetylation of the neighboring lysine 14 and recruitment of activated RNA polymerase II in response to trichostatin A treatment. In non-induced cells, the protein phosphatase PP2A is associated with the p21 gene and counteracts its activation. Induction of p21 is linked to simultaneous acetylation and phosphorylation of histone H3. The dual modification mark H3S10phK14ac at the activated p21 promoter is recognized by the phospho-binding protein 14-3-3ζ, which protects the phosphoacetylation mark from being processed by PP2A. Taken together we have revealed a cross-talk of reversible phosphorylation and acetylation signals that controls the activation of p21 by HDAC inhibitors and identify the phosphatase PP2A as chromatin-associated transcriptional repressor in mammalian cells.

UR - http://www.scopus.com/inward/record.url?scp=78650342693&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650342693&partnerID=8YFLogxK

U2 - 10.1074/jbc.M110.184481

DO - 10.1074/jbc.M110.184481

M3 - Article

C2 - 20952396

AN - SCOPUS:78650342693

VL - 285

SP - 41062

EP - 41073

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 52

ER -